Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Lippo Karawaci Tbk. (LPKR) Price & Performance

UBC Medical Indonesia Tbk.Trade
Lippo Karawaci Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Lippo Karawaci Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Lippo Karawaci Tbk. trades at Rp61 (market cap 4.32T, 78.75M 24h volume). The key difference: Lippo Karawaci Tbk. is far larger — about 6.2× UBC Medical Indonesia Tbk.'s market cap, and Lippo Karawaci Tbk. is more actively traded (78.75M versus 635.5K). Which is the better fit depends on your goals.

LABSLPKR
Market Cap
691.25B4.32T
Volume
635.5K78.75M
Lot
6.36K787.51K
Turnover
110.15M4.81B
Average Price
173.3361.05
Value
110.15M4.81B
Indicative Equilibrium Price
17461
Indicative Equilibrium Volume
5028.62K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
LPKR
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Lippo Karawaci Tbk.

PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.

Read more on LPKR